160 related articles for article (PubMed ID: 10220485)
1. Metabolism of (R)-(+)-pulegone and (R)-(+)-menthofuran by human liver cytochrome P-450s: evidence for formation of a furan epoxide.
Khojasteh-Bakht SC; Chen W; Koenigs LL; Peter RM; Nelson SD
Drug Metab Dispos; 1999 May; 27(5):574-80. PubMed ID: 10220485
[TBL] [Abstract][Full Text] [Related]
2. The metabolism of the abortifacient terpene, (R)-(+)-pulegone, to a proximate toxin, menthofuran.
Gordon WP; Huitric AC; Seth CL; McClanahan RH; Nelson SD
Drug Metab Dispos; 1987; 15(5):589-94. PubMed ID: 2891472
[TBL] [Abstract][Full Text] [Related]
3. Menthofuran-dependent and independent aspects of pulegone hepatotoxicity: roles of glutathione.
Thomassen D; Slattery JT; Nelson SD
J Pharmacol Exp Ther; 1990 May; 253(2):567-72. PubMed ID: 2338648
[TBL] [Abstract][Full Text] [Related]
4. Glutathione S-transferase catalyzes the isomerization of (R)-2-hydroxymenthofuran to mintlactones.
Khojasteh-Bakht SC; Nelson SD; Atkins WM
Arch Biochem Biophys; 1999 Oct; 370(1):59-65. PubMed ID: 10496977
[TBL] [Abstract][Full Text] [Related]
5. Investigations of mechanisms of reactive metabolite formation from (R)-(+)-pulegone.
Nelson SD; McClanahan RH; Thomassen D; Gordon WP; Knebel N
Xenobiotica; 1992; 22(9-10):1157-64. PubMed ID: 1441606
[TBL] [Abstract][Full Text] [Related]
6. Human cytochrome P-450 metabolism of retinals to retinoic acids.
Zhang QY; Dunbar D; Kaminsky L
Drug Metab Dispos; 2000 Mar; 28(3):292-7. PubMed ID: 10681373
[TBL] [Abstract][Full Text] [Related]
7. Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes.
Miyazawa M; Shindo M; Shimada T
Drug Metab Dispos; 2001 Feb; 29(2):200-5. PubMed ID: 11159812
[TBL] [Abstract][Full Text] [Related]
8. Demonstration that menthofuran synthase of mint (Mentha) is a cytochrome P450 monooxygenase: cloning, functional expression, and characterization of the responsible gene.
Bertea CM; Schalk M; Karp F; Maffei M; Croteau R
Arch Biochem Biophys; 2001 Jun; 390(2):279-86. PubMed ID: 11396930
[TBL] [Abstract][Full Text] [Related]
9. Eight inhibitory monoclonal antibodies define the role of individual P-450s in human liver microsomal diazepam, 7-ethoxycoumarin, and imipramine metabolism.
Yang TJ; Krausz KW; Sai Y; Gonzalez FJ; Gelboin HV
Drug Metab Dispos; 1999 Jan; 27(1):102-9. PubMed ID: 9884317
[TBL] [Abstract][Full Text] [Related]
10. Identification of the human liver microsomal cytochrome P450s involved in the metabolism of N-nitrosodi-n-propylamine.
Teiber JF; Hollenberg PF
Carcinogenesis; 2000 Aug; 21(8):1559-66. PubMed ID: 10910959
[TBL] [Abstract][Full Text] [Related]
11. Contribution of menthofuran to the hepatotoxicity of pulegone: assessment based on matched area under the curve and on matched time course.
Thomassen D; Slattery JT; Nelson SD
J Pharmacol Exp Ther; 1988 Mar; 244(3):825-9. PubMed ID: 3252034
[TBL] [Abstract][Full Text] [Related]
12. Reactive intermediates in the oxidation of menthofuran by cytochromes P-450.
Thomassen D; Knebel N; Slattery JT; McClanahan RH; Nelson SD
Chem Res Toxicol; 1992; 5(1):123-30. PubMed ID: 1581528
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of (R)-(+)-menthofuran in Fischer-344 rats: identification of sulfonic acid metabolites.
Chen LJ; Lebetkin EH; Burka LT
Drug Metab Dispos; 2003 Oct; 31(10):1208-13. PubMed ID: 12975329
[TBL] [Abstract][Full Text] [Related]
14. The metabolism of the piperazine-type phenothiazine neuroleptic perazine by the human cytochrome P-450 isoenzymes.
Wójcikowski J; Pichard-Garcia L; Maurel P; Daniel WA
Eur Neuropsychopharmacol; 2004 May; 14(3):199-208. PubMed ID: 15056479
[TBL] [Abstract][Full Text] [Related]
15. (R)-(+)-Menthofuran is a potent, mechanism-based inactivator of human liver cytochrome P450 2A6.
Khojasteh-Bakht SC; Koenigs LL; Peter RM; Trager WF; Nelson SD
Drug Metab Dispos; 1998 Jul; 26(7):701-4. PubMed ID: 9660853
[TBL] [Abstract][Full Text] [Related]
16. Multiple cytochrome P-450s involved in the metabolism of terbinafine suggest a limited potential for drug-drug interactions.
Vickers AE; Sinclair JR; Zollinger M; Heitz F; Glänzel U; Johanson L; Fischer V
Drug Metab Dispos; 1999 Sep; 27(9):1029-38. PubMed ID: 10460803
[TBL] [Abstract][Full Text] [Related]
17. Role of C-5 chiral center in R-(+)-pulegone-mediated hepatotoxicity: metabolic disposition and toxicity of 5, 5-dimethyl-2-(1-Methylethylidene)-cyclohexanone in rats.
Thulasiram HV; Gadad AK; Madyastha MK
Drug Metab Dispos; 2000 Jul; 28(7):833-44. PubMed ID: 10859158
[TBL] [Abstract][Full Text] [Related]
18. Rapid characterization of the major drug-metabolizing human hepatic cytochrome P-450 enzymes expressed in Escherichia coli.
McGinnity DF; Griffin SJ; Moody GC; Voice M; Hanlon S; Friedberg T; Riley RJ
Drug Metab Dispos; 1999 Sep; 27(9):1017-23. PubMed ID: 10460801
[TBL] [Abstract][Full Text] [Related]
19. Identification of the human liver cytochrome P450 isoenzyme responsible for the 6-methylhydroxylation of the novel anticancer drug 5,6-dimethylxanthenone-4-acetic acid.
Zhou S; Paxton JW; Tingle MD; Kestell P
Drug Metab Dispos; 2000 Dec; 28(12):1449-56. PubMed ID: 11095582
[TBL] [Abstract][Full Text] [Related]
20. Partial characterization of biliary metabolites of pulegone by tandem mass spectrometry. Detection of glucuronide, glutathione, and glutathionyl glucuronide conjugates.
Thomassen D; Pearson PG; Slattery JT; Nelson SD
Drug Metab Dispos; 1991; 19(5):997-1003. PubMed ID: 1686249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
